Hariyana-CHO-2021
Child Health Nursing (Pediatrics)
Easy

The dose of deworming tablets (Albendazole) given below 1 year old child is?

Appeared in: Hariyana-CHO-2021

Explanation

  • Albendazole is not recommended for infants under 12 months of age due to a lack of safety data in this age group.
  • National and international deworming guidelines, including those from the WHO, initiate mass drug administration with Albendazole starting from the age of 1 year (12 months).
  • The primary strategy for infants is prevention through improved sanitation and hygiene rather than pharmacological treatment.

Why Other Options Were Wrong

  • Option A: This dose is for a different pediatric age group.
  • Option B: This dose is for older children and adults.
  • Option D: This is not a standard or recognized dosage for Albendazole in deworming protocols.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: Use the key finding related to Pediatric dosage of Albendazole for deworming to guide bedside assessment, documentation, and the next nursing action.
  • A nurse's primary responsibility is to ensure medication safety, which includes verifying the correct dose for the patient's age and weight. Administering Albendazole to an infant under 1 year would be a medication error.
  • Patient education is a key nursing role. Nurses should instruct caregivers on how to prevent worm infestations by promoting hand hygiene, safe food and water practices, and the use of footwear.
  • What if? If a child is exactly 12 months old, the nurse should administer the recommended 200 mg dose (half of a 400 mg tablet), crushing it and mixing it with a small amount of food or water to ensure safe swallowing.
How to Approach the Question
  • First, identify the core of the question: the correct dose of Albendazole for an infant under 1 year old.
  • Recall knowledge from pharmacology and community health nursing regarding national deworming programs.
  • Remember the specific age contraindication for Albendazole, which is a critical safety point.
  • Evaluate the options based on this key piece of information. The option 'Not to be given' directly aligns with the contraindication for children under 12 months.
  • Confirm that the other dosage options (200 mg and 400 mg) are for older age groups (1-2 years and >2 years, respectively), reinforcing the correctness of the chosen answer.
Concept Tested & Keywords
  • Concept Tested: Pediatric dosage of Albendazole for deworming.
  • Stem keywords: dose, deworming, Albendazole, below 1 year old child
  • Lead-in keywords: is
  • Clinical cues: Age/sex group narrows the expected diagnosis, intervention, or normal reference range.
  • Negative lead-in flag: false

Question ID

QT_aChjyCl8PMw9vt0FJCa

Reference Book

E6 Ghai Essential Pediatrics(pp 26-904 of 913) p. 846-848

E6 Parks TextBook of Preventive & Social Medicine part 1 — Subpart B (pp 202-403 of 604) p. 101-103

Practise the full Hariyana-CHO-2021

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Otolaryngology Questions

More Hariyana-CHO-2021 Questions